|
1
|
Sham JS, Wei WI, Zong YS, Choy D, Guo YQ,
Luo Y, Lin ZX and Ng MH: Detection of subclinical nasopharyngeal
carcinoma by fibreoptic endoscopy and multiple biopsy. Lancet.
335:371–374. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Feng X, Ren C, Zhou W, Liu W, Zeng L, Li
G, Wang L, Li M, Zhu B, Yao K, et al: Promoter hypermethylation
along with LOH, but not mutation, contributes to inactivation of
DLC-1 in nasopharyngeal carcinoma. Mol Carcinog. 53:858–870. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang L, Chen QY, Liu H, Tang LQ and Mai
HQ: Emerging treatment options for nasopharyngeal carcinoma. Drug
Des Devel Ther. 7:37–52. 2013.PubMed/NCBI
|
|
4
|
Brückner A, Polge C, Lentze N, Auerbach D
and Schlattner U: Yeast two-hybrid, a powerful tool for systems
biology. Int J Mol Sci. 10:2763–2788. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
James P, Halladay J and Craig EA: Genomic
libraries and a host strain designed for highly efficient
two-hybrid selection in yeast. Genetics. 144:1425–1436.
1996.PubMed/NCBI
|
|
6
|
Yang XY, Ren CP, Wang L, Li H, Jiang CJ,
Zhang HB, Zhao M and Yao KT: Identification of differentially
expressed genes in metastatic and non-metastatic nasopharyngeal
carcinoma cells by suppression subtractive hybridization. Cell
Oncol. 27:215–223. 2005.PubMed/NCBI
|
|
7
|
Wen Q, Li J, Wang W, Xie G, Xu L, Luo J,
Chu S, She L, Li D, Huang D, et al: Increased expression of
flotillin-2 protein as a novel biomarker for lymph node metastasis
in nasopharyngeal carcinoma. PLoS One. 9:e1016762014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu J, Huang W, Ren C, Wen Q, Liu W, Yang
X, Wang L, Zhu B, Zeng L, Feng X, et al: Flotillin-2 promotes
metastasis of nasopharyngeal carcinoma by activating NF-κB and
PI3K/Akt3 signaling pathways. Sci Rep. 5:116142015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cao K, Xie D, Cao P, Zou Q, Lu C, Xiao S,
Zhou J and Peng X: SiRNA-mediated flotillin-2 (Flot2)
downregulation inhibits cell proliferation, migration, and invasion
in gastric carcinoma cells. Oncol Res. 21:271–279. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nishizuka Y: Protein kinase C and lipid
signaling for sustained cellular responses. FASEB J. 9:484–496.
1995.PubMed/NCBI
|
|
11
|
De Smedt H and Parys JB: Molecular and
functional diversity of inositol triphosphate-induced
Ca2+ release. Verh K Acad Geneeskd Belg. 57:423–458.
1995.(In Dutch). PubMed/NCBI
|
|
12
|
Berridge MJ: Inositol trisphosphate and
calcium signalling. Nature. 361:315–325. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cockcroft S and Thomas GM:
Inositol-lipid-specific phospholipase C isoenzymes and their
differential regulation by receptors. Biochem J. 288:1–14. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rhee SG and Bae YS: Regulation of
phosphoinositide-specific phospholipase C isozymes. J Biol Chem.
272:15045–15048. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kelley GG, Reks SE, Ondrako JM and Smrcka
AV: Phospholipase C(epsilon): A novel Ras effector. EMBO J.
20:743–754. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Harden TK and Sondek J: Regulation of
phospholipase C isozymes by ras superfamily GTPases. Annu Rev
Pharmacol Toxicol. 46:355–379. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Katan M and Williams RL:
Phosphoinositide-specific phospholipase C: Structural basis for
catalysis and regulatory interactions. Semin Cell Dev Biol.
8:287–296. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rhee SG: Reflections on the days of
phospholipase C. Adv Biol Regul. 53:223–231. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
García del Caño G, Montaña M, Aretxabala
X, González-Burguera I, López de Jesús M, Barrondo S and Sallés J:
Nuclear phospholipase C-β1 and diacylglycerol LIPASE-α in brain
cortical neurons. Adv Biol Regul. 54:12–23. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Koh HY: Phospholipase C-β1 and
schizophrenia-related behaviors. Adv Biol Regul. 53:242–248. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Follo MY, Faenza I, Fiume R, Ramazzotti G,
McCubrey JA, Martelli AM, Manzoli FA and Cocco L: Revisiting
nuclear phospholipase C signalling in MDS. Adv Biol Regul. 52:2–6.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Follo MY, Marmiroli S, Faenza I, Fiume R,
Ramazzotti G, Martelli AM, Gobbi P, McCubrey JA, Finelli C, Manzoli
FA, et al: Nuclear phospholipase C β1 signaling, epigenetics and
treatments in MDS. Adv Biol Regul. 53:2–7. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Manzoli L, Mongiorgi S, Clissa C, Finelli
C, Billi AM, Poli A, Quaranta M, Cocco L and Follo MY: Strategic
role of nuclear inositide signalling in myelodysplastic syndromes
therapy. Mini Rev Med Chem. 14:873–883. 2014. View Article : Google Scholar
|
|
24
|
Zaidi SK, Trombly DJ, Dowdy CR, Lian JB,
Stein JL, van Wijnen AJ and Stein GS: Epigenetic mechanisms in
leukemia. Adv Biol Regul. 52:369–376. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Barker CJ, Li L, Köhler M and Berggren PO:
β-Cell Ca2+ dynamics and function are compromised in
aging. Adv Biol Regul. 57:112–119. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jang HJ, Yang YR, Kim JK, Choi JH, Seo YK,
Lee YH, Lee JE, Ryu SH and Suh PG: Phospholipase C-γ1 involved in
brain disorders. Adv Biol Regul. 53:51–62. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lattanzio R, Piantelli M and Falasca M:
Role of phospholipase C in cell invasion and metastasis. Adv Biol
Regul. 53:309–318. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Arteaga CL, Johnson MD, Todderud G, Coffey
RJ, Carpenter G and Page DL: Elevated content of the tyrosine
kinase substrate phospholipase C-gamma 1 in primary human breast
carcinomas. Proc Natl Acad Sci USA. 88:pp. 10435–10439. 1991;
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nakamura Y, Kanemarum K and Fukami K:
Physiological functions of phospholipase Cδ1 and phospholipase Cδ3.
Adv Biol Regul. 53:356–362. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shimohama S, Perry G, Richey P, Takenawa
T, Whitehouse PJ, Miyoshi K, Suenaga T, Matsumoto S, Nishimura M
and Kimura J: Abnormal accumulation of phospholipase C-delta in
filamentous inclusions of human neurodegenerative diseases.
Neurosci Lett. 162:183–186. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shimohama S, Homma Y, Suenaga T, Fujimoto
S, Taniguchi T, Araki W, Yamaoka Y, Takenawa T and Kimura J:
Aberrant accumulation of phospholipase C-delta in Alzheimer brains.
Am J Pathol. 139:737–742. 1991.PubMed/NCBI
|
|
32
|
Fu L, Qin YR, Xie D, Hu L, Kwong DL,
Srivastava G, Tsao SW and Guan XY: Characterization of a novel
tumor-suppressor gene PLC delta 1 at 3p22 in esophageal squamous
cell carcinoma. Cancer Res. 67:10720–10726. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hu XT, Zhang FB, Fan YC, Shu XS, Wong AH,
Zhou W, Shi QL, Tang HM, Fu L, Guan XY, et al: Phospholipase C
delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton
organization, with its epigenetic silencing correlated with
high-stage gastric cancer. Oncogene. 28:2466–2475. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chan JJ and Katan M: PLCε and the RASSF
family in tumour suppression and other functions. Adv Biol Regul.
53:258–279. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang X, Zbou C, Qiu G, Fan J, Tang H and
Peng Z: Screening of new tumor suppressor genes in sporadic
colorectal cancer patients. Hepatogastroenterology. 55:2039–2044.
2008.PubMed/NCBI
|
|
36
|
Amdani SN, Jones C and Coward K:
Phospholipase C zeta (PLCζ): Oocyte activation and clinical links
to male factor infertility. Adv Biol Regul. 53:292–308. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xiao W, Hong H, Kawakami Y, Kato Y, Wu D,
Yasudo H, Kimura A, Kubagawa H, Bertoli LF, Davis RS, et al: Tumor
suppression by phospholipase C-beta3 via SHP-1-mediated
dephosphorylation of Stat5. Cancer Cell. 16:161–171. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shi J, Ren C, Liu H, Wang L, Zhu B, Huang
W, Liu W, Liu J, Liu Y, Xia X, et al: An ESRG-interacting protein,
COXII, is involved in pro-apoptosis of human embryonic stem cells.
Biochem Biophys Res Commun. 460:130–135. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wanggou S, Jiang X, Li Q, Zhang L, Liu D,
Li G, Feng X, Liu W, Zhu B, Huang W, et al: HESRG: A novel
biomarker for intracranial germinoma and embryonal carcinoma. J
Neurooncol. 106:251–259. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tang G, Liu D, Xiao G, Liu Q and Yuan J:
Transcriptional repression of FOXO1 by KLF4 contributes to glioma
progression. Oncotarget. 7:81757–81767. 2016.PubMed/NCBI
|
|
41
|
Zhou W, Feng X, Ren C, Jiang X, Liu W,
Huang W, Liu Z, Li Z, Zeng L, Wang L, et al: Over-expression of
BCAT1, a c-Myc target gene, induces cell proliferation, migration
and invasion in nasopharyngeal carcinoma. Mol Cancer. 12:532013.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang H, Feng X, Liu W, Jiang X, Shan W,
Huang C, Yi H, Zhu B, Zhou W, Wang L, et al: Underlying mechanisms
for LTF inactivation and its functional analysis in nasopharyngeal
carcinoma cell lines. J Cell Biochem. 112:1832–1843. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Feng X, Li C, Liu W, Chen H, Zhou W, Wang
L, Zhu B, Yao K, Jiang X and Ren C: DLC-1, a candidate tumor
suppressor gene, inhibits the proliferation, migration and
tumorigenicity of human nasopharyngeal carcinoma cells. Int J
Oncol. 42:1973–1984. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hazarika P, McCarty MF, Prieto VG, George
S, Babu D, Koul D, Bar-Eli M and Duvic M: Up-regulation of
Flotillin-2 is associated with melanoma progression and modulates
expression of the thrombin receptor protease activated receptor 1.
Cancer Res. 64:7361–7369. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gómez V, Sesé M, Santamaría A, Martínez
JD, Castellanos E, Soler M, Thomson TM and Paciucci R: Regulation
of aurora B kinase by the lipid raft protein flotillin-1. J Biol
Chem. 285:20683–20690. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Satyamoorthy K, Li G, Gerrero MR, Brose
MS, Volpe P, Weber BL, Van Belle P, Elder DE and Herlyn M:
Constitutive mitogen-activated protein kinase activation in
melanoma is mediated by both BRAF mutations and autocrine growth
factor stimulation. Cancer Res. 63:756–759. 2003.PubMed/NCBI
|
|
47
|
Liu Y, Lin L, Huang Z, Ji B, Mei S, Lin Y
and Shen Z: High expression of flotillin-2 is associated with poor
clinical survival in cervical carcinoma. Int J Clin Exp Pathol.
8:622–628. 2015.PubMed/NCBI
|
|
48
|
Berger T, Ueda T, Arpaia E, Chio II,
Shirdel EA, Jurisica I, Hamada K, You-Ten A, Haight J, Wakeham A,
et al: Flotillin-2 deficiency leads to reduced lung metastases in a
mouse breast cancer model. Oncogene. 32:4989–4994. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wang YL, Yao WJ, Guo L, Xi HF, Li SY and
Wang ZM: Expression of flotillin-2 in human non-small cell lung
cancer and its correlation with tumor progression and patient
survival. Int J Clin Exp Pathol. 8:601–607. 2015.PubMed/NCBI
|
|
50
|
Lin C, Wu Z, Lin X, Yu C, Shi T, Zeng Y,
Wang X, Li J and Song L: Knockdown of FLOT1 impairs cell
proliferation and tumorigenicity in breast cancer through
upregulation of FOXO3a. Clin Cancer Res. 17:3089–3099. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yan Y, Yang FQ, Zhang HM, Che J and Zheng
JH: Up-regulation of flotillin-2 is associated with renal cell
carcinoma progression. Tumour Biol. 35:10479–10486. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhao L, Lin L, Pan C, Shi M, Liao Y, Bin J
and Liao W: Flotillin-2 promotes nasopharyngeal carcinoma
metastasis and is necessary for the epithelial-mesenchymal
transition induced by transforming growth factor-β. Oncotarget.
6:9781–9793. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Takano N, Iizuka N, Hazama S, Yoshino S,
Tangoku A and Oka M: Expression of estrogen receptor-alpha and
-beta mRNAs in human gastric cancer. Cancer Lett. 176:129–135.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Nakamura Y, Hamada Y, Fujiwara T, Enomoto
H, Hiroe T, Tanaka S, Nose M, Nakahara M, Yoshida N, Takenawa T, et
al: Phospholipase C-delta1 and -delta3 are essential in the
trophoblast for placental development. Mol Cell Biol.
25:10979–10988. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Nakamura Y, Kanemaru K, Kojima R,
Hashimoto Y, Marunouchi T, Oka N, Ogura T, Tanonaka K and Fukami K:
Simultaneous loss of phospholipase Cδ1 and phospholipase Cδ3 causes
cardiomyocyte apoptosis and cardiomyopathy. Cell Death Dis.
5:e12152014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Kouchi Z, Igarashi T, Shibayama N, Inanobe
S, Sakurai K, Yamaguchi H, Fukuda T, Yanagi S, Nakamura Y and
Fukami K: Phospholipase Cdelta3 regulates RhoA/Rho kinase signaling
and neurite outgrowth. J Biol Chem. 286:8459–8471. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Rebecchi MJ, Raghubir A, Scarlata S,
Hartenstine MJ, Brown T and Stallings JD: Expression and function
of phospholipase C in breast carcinoma. Adv Enzyme Regul. 49:59–73.
2009. View Article : Google Scholar : PubMed/NCBI
|
